Merkel Cell Carcinoma: The Rare and Aggressive Skin Cancer You Should Know
When singer-songwriter Jimmy Buffett revealed his diagnosis of Merkel cell carcinoma in 2019, few people had heard of this rare skin cancer. Buffett continued performing throughout treatment, but ultimately succumbed to the disease in September 2023 at age 76, four years after diagnosis. His high-profile case brought attention to one of skin cancer’s most aggressive forms—one that kills more readily than melanoma yet remains largely unknown to the public.
Merkel cell carcinoma (MCC) is a rare, aggressive form of skin cancer with a high risk for returning (recurring) and spreading (metastasizing), often within two to three years after initial diagnosis. Approximately 3,000 new cases of Merkel cell skin cancer are diagnosed annually in the U.S. About 40 percent of cases recur. Merkel cell carcinoma (MCC) is 40 times more rare than melanoma, with an estimated one case per 130,000 people in the U.S. Skin Cancer Foundation.
Despite its rarity, MCC demands attention. Merkel cell carcinoma is a rare but aggressive type of skin cancer. It’s the second most common cause of skin cancer-related death after melanoma. Merkel cell carcinoma can spread easily to another region of the body and has high recurrence rates—with one review finding that about 30 percent of patients whose cancers were caught in early or mid stages had a recurrence on the skin City of Hope.
What It Looks Like And Who Gets It
Merkel cell tumors often look like firm, pink, red, or purple lumps or bumps on the skin. They usually don’t hurt, but they tend to grow quickly and can sometimes open up as ulcers or sores. Merkel cell carcinomas can start anywhere on the skin, but most often they start on skin that’s exposed to the sun, like the face (the most common site), neck, and arms American Cancer Society.
This aggressive skin cancer can look like a rapidly growing stye or cyst. Unlike a stye or cyst, Merkel cell carcinoma often feels painless. Sometimes, this aggressive skin cancer looks like a sore. MCC tends to grow quickly—it usually becomes noticeably bigger in a few weeks to months. It appears after 50 years of age: Research shows that 97% of people who develop this rare skin cancer are older than 50. Most people are in their 70s or 80s when diagnosed with MCC AAD.
The rapid growth distinguishes MCC from other skin cancers. A harmless-looking bump that doubles in size over weeks raises red flags. Many patients initially mistake MCC for an infected cyst or insect bite, delaying diagnosis until the cancer has spread.
Merkel cell carcinoma is a very rare type of skin cancer, affecting approximately 3,000 Americans every year. However, the number of people receiving a Merkel cell carcinoma diagnosis is steadily increasing. This increase may be due to improved diagnostic tests. The condition also tends to affect people older than 70. As people live longer, they may be more likely to develop this cancer Cleveland Clinic.
The Viral Connection
Unlike most skin cancers driven solely by UV exposure, MCC has an unusual cause. Around 80% of cases of Merkel cell cancer in the U.S. are caused by infection by a virus called Merkel cell polyomavirus (MCPyV). MCPyV is a common virus; roughly 60% to 80% of people have been infected by it Yale Medicine.
Eight in 10 people with Merkel cell carcinoma have the Merkel cell polyomavirus (MCP). But most people infected with MCP don’t develop Merkel cell carcinoma Cleveland Clinic. The virus typically causes no problems in healthy people with functioning immune systems. However, in immunocompromised individuals—organ transplant recipients, people with HIV, those with chronic lymphocytic leukemia, or simply older adults with aging immune systems—the virus can transform normal skin cells into cancer.
How It Spreads And Survival Rates
Merkel cell carcinoma is an aggressive cancer that spreads quickly to other parts of your body. Merkel cell carcinoma most commonly spreads to your lymphatic system (lymph nodes) first. From there, it may spread to other parts of your body like your bones, lungs, brain or other organs Cleveland Clinic.
The numbers tell a sobering story. While rare, Merkel cell carcinoma is aggressive. It is the second leading cause of skin cancer death, after melanoma. If the disease is caught before it has spread, the five-year survival rate is 75%. If the cancer has spread to the lymph nodes, it is 64%. Merkel cell carcinoma that has spread to distant sites has a 24% survival rate MD Anderson Cancer Center.
According to the SEER database, the overall five-year relative survival rate for Merkel cell carcinoma is 64 percent. The detailed breakdown for five-year relative survival rates is: Localized (Merkel cell carcinoma that was caught early before spreading): 76 percent. Regional (patients with spread to nearby tissues or lymph nodes): 56 percent. Distant (patients with cancer that has spread to distant parts of the body): 23 percent City of Hope.
Many factors — like your overall health, age and cancer stage — influence survival rates. Experts estimate that 3 out of 4 people who have localized Merkle cell carcinoma (cancer that hasn’t spread) are alive five years after diagnosis. That number drops to 1 in 4 when you have metastatic cancer Cleveland Clinic.
Treatment: The Immunotherapy Revolution
Traditional treatment involves wide surgical excision—cutting out the tumor with 1-2 cm margins of surrounding healthy tissue. Because MCC is highly sensitive to radiation, radiation therapy often follows surgery to reduce recurrence risk. For years, chemotherapy offered limited benefit for metastatic disease, with poor response rates and significant toxicity.
Then immunotherapy changed everything. For metastatic MCC, immunotherapy has become the preferred systemic treatment, offering improved progression-free survival and durable responses compared to traditional chemotherapy NCBI. Checkpoint inhibitors—drugs that unleash the immune system to attack cancer—have revolutionized MCC treatment. Avelumab, pembrolizumab, and nivolumab show remarkable response rates of 40-56% in metastatic disease, with many responses lasting years.
Fortunately, options for managing recurrent disease have increased markedly with the introduction of immunotherapy treatments. While MCC is about three to five times more likely to be deadly than melanoma, with early detection, MCC can be treated successfully Skin Cancer Foundation.
Clinical trials are exploring adjuvant immunotherapy—giving checkpoint inhibitors after surgery to prevent recurrence in high-risk patients. Early results suggest this approach may significantly reduce recurrence rates and improve survival.
Although Merkel cell carcinoma is one of the most dangerous forms of skin cancer, the majority (75%) of people survive five years or more after diagnosis when the cancer has not spread Yale Medicine. The key: catching it early. Any rapidly growing, painless bump—especially in someone over 50 with sun-damaged skin or a weakened immune system—deserves immediate medical evaluation. What looks harmless could be Merkel cell carcinoma, and in this cancer, timing determines everything.
References
- Skin Cancer Foundation. Merkel Cell Carcinoma Overview. https://www.skincancer.org/skin-cancer-information/merkel-cell-carcinoma/
- Cleveland Clinic. Merkel Cell Carcinoma: Symptoms, Causes, Stages & Treatment. https://my.clevelandclinic.org/health/diseases/17971-merkel-cell-carcinoma
- MD Anderson. Merkel Cell Carcinoma. https://www.mdanderson.org/cancer-types/skin-cancer/merkel-cell-carcinoma.html
- American Academy of Dermatology. Merkel cell carcinoma signs & symptoms. https://www.aad.org/public/diseases/skin-cancer/types/common/merkel-cell/symptoms
- Yale Medicine. Merkel Cell Carcinoma (MCC). https://www.yalemedicine.org/conditions/merkel-cell-carcinoma-mcc
Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.
